L. Knudsen
Endocrinology, Diabetes and Metabolism · Journal of Medicinal Chemistry · 2000–2020
A researcher in the Science corpus: 5 papers; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Endocrinology, Diabetes and Metabolism — 32 citations into it
- Surgery — 25 citations into it
Whom L. Knudsen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from L. Knudsen's perspective
Ordered by how strongly the researchers L. Knudsen trusts endorse each paper. Same corpus, a different order for every researcher.
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. (New England Journal of Medicine)
- Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. (Endocrinology)
- Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. (Journal of Molecular Biology)
- A Molecular Census of Arcuate Hypothalamus and Median Eminence Cell Types
- Anatomy and regulation of the central melanocortin system (Nature Neuroscience)
- Impact of albumin on drug delivery--new applications on the horizon. (Journal of Controlled Release)
- NPY/AgRP Neurons Are Essential for Feeding in Adult Mice but Can Be Ablated in Neonates (Science)
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. (The Lancet)
- Glucagon-like peptide-1 receptor is involved in learning and neuroprotection (Nature Medicine)
- The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. (Journal of Clinical Investigation)
Their papers
- Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. (2015) — 939 citations
- GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody. (2014) — 791 citations
- Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. (2000) — 715 citations
- Semaglutide lowers body weight in rodents via distributed neural pathways. (2020) — 598 citations
- The Discovery and Development of Liraglutide and Semaglutide (2019) — 783 citations